Previously, Hurts was diagnosed with a superficial blood clot in his calf after an incident in Week 4. New medical evaluations, however, revealed a more serious development: deep vein thrombosis in the leg and bilateral pulmonary emboli. This combination places Hurts at risk of further complications and requires careful management with blood-thinning treatment. The updated prognosis indicates that he will miss the remainder of the season as doctors determine the best path forward for recovery.
In the immediate aftermath of these findings, reports surfaced detailing Hurts’s hospital stay. Insiders noted that he remained in the hospital overnight prior to the Week 5 matchup in London, undergoing a battery of tests. The information suggested that sleep was considered a health risk given the circumstances, complicating the decision-making process around his ability to play in the London game.
Despite the medical concerns and the lack of sleep, Hurts played in Week 5. This decision has prompted scrutiny and questions about how teams assess risk when a top quarterback faces a potentially dangerous medical situation. While players often want to compete and push through adversity, medical guidance must weigh the immediate harms against the potential long-term consequences of continuing to play.
The situation drew comments from Hurts’s agent, who provided context about the evolving diagnosis. Initially, London-based specialists diagnosed a left calf superficial vein thrombosis. Subsequent evaluations indicated a deep vein thrombosis and bilateral pulmonary emboli. The agent emphasized that Hurts is clinically stable and not experiencing significant functional limitations at this time. The plan involves ongoing treatment with anticoagulants and close monitoring to facilitate a safe recovery.
Looking ahead, the medical team’s focus will be on stabilizing Hurts, mitigating the risk of further clots, and determining when he can resume football activities. The prognosis, according to the agent, is favorable, with expectations of a full recovery. However, the schedule for return to play will depend on a range of clinical factors, including imaging results, symptom progression, and the patient’s response to treatment. At this stage, the consensus is that Hurts will not return this season, though the ultimate timeline will be guided by medical professionals.
This developing story underscores the importance of patient safety and medical judgment in professional sports. While athletes are known for their determination and willingness to push through pain, medical decisions should prioritize long-term health over short-term competition. The balance between urgent performance and patient well-being is delicate, and the ongoing evaluation will aim to protect Hurts from avoidable complications while enabling a safe, effective recovery pathway.
As the situation evolves, fans, analysts, and team staff will be watching closely to understand the full impact on the team’s plans for the coming seasons. The focus remains on Hurts’s health, the effectiveness of the treatment protocol, and the timeline for a potential return to the field, should medical counsel clear him in the future. This incident serves as a reminder of the seriousness of clot-related conditions and the critical role of medical oversight in high-stakes professional sports.
